Patents by Inventor Scott Burkholtz

Scott Burkholtz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONTROLLED RELEASE OF ANTIBODIES TO MODULATE CYTOKINES
    Publication number: 20210292406
    Abstract: An injectable formulation, comprising: poly(lactic-co-glycolic (PLGA) microsphere encapsulating siltuximab, wherein microspheres are sized to release siltuximab over a period of hours, days and weeks, where the biocompatible polymer releases antibody at an absorption rate which is characterized by an absorption rate constant (Ka (h?1) in the range of (0.001 to 2.048)+/?20%, or +/?10%, or +/?5%. for use and treating human patients with infections. The invention includes treating patients with viral infections of SARS-Cov-2 using siltuximab.
    Type: Application
    Filed: March 16, 2021
    Publication date: September 23, 2021
    Applicant: Flow Pharma, Inc.
    Inventors: Reid M. Rubsamen, Scott Burkholtz, Charles V. Herst, Tom Hodge, Lu Wang